/
ELUT
$0.85+$0.04 (+5.17%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$36.2M
44M shares
52-week range
$0.50 – $2.50
18% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-0.56
Elutia Inc. Class A Common Stock
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
www.elutia.com- Employees
- 26
- IPO / List date
- Oct 8, 2020
- HQ
- SILVER SPRING, MD
Held by traders on TradeandTell
No one on the platform currently holds ELUT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 82,716 | $86.9K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ELUT yet.
